| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks | Aug 09, 2023 | Buy | $2.38 | 10,000 | 23,794 | 2,288,064 | Aug 09, 2023, 06:57 PM | |
| XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks | Dec 13, 2022 | Buy | $1.45 | 20,000 | 29,000 | 1,528,064 | Dec 14, 2022, 04:11 PM | |
| XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks | May 12, 2022 | Buy | $1.40 | 100,000 | 140,380 | 1,508,064 | May 13, 2022, 04:19 PM | |
| XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks | Nov 15, 2021 | Buy | $2.28 | 20,000 | 45,664 | 33,430 | Nov 16, 2021, 04:25 PM | |
| XERS | Xeris Biopharma Holdings, Inc. | Edick Paul R | See Remarks | Nov 11, 2021 | Buy | $2.08 | 200,000 | 415,760 | 808,064 | Nov 12, 2021, 05:09 PM | |
| XERS | XERIS PHARMACEUTICALS INC | Edick Paul R | See Remarks | Dec 09, 2020 | Buy | $4.06 | 10,000 | 40,551 | 411,134 | Dec 10, 2020, 04:52 PM | |
| XERS | XERIS PHARMACEUTICALS INC | Edick Paul R | See Remarks | May 08, 2020 | Buy | $3.00 | 33,000 | 99,000 | 401,134 | May 11, 2020, 05:06 PM | |
| XERS | XERIS PHARMACEUTICALS INC | Edick Paul R | See Remarks | Feb 14, 2020 | Buy | $4.15 | 20,000 | 83,000 | 183,134 | Feb 18, 2020, 05:02 PM | |
| XERS | XERIS PHARMACEUTICALS INC | Edick Paul R | See Remarks | Jan 31, 2020 | Option Exercise | $6.37 | 9,801 | 62,432 | 163,134 | Feb 04, 2020, 05:00 PM | |
| XERS | XERIS PHARMACEUTICALS INC | Edick Paul R | See Remarks | Nov 25, 2019 | Buy | $8.55 | 17,935 | 153,283 | 172,935 | Nov 27, 2019, 04:43 PM | |
| XERS | XERIS PHARMACEUTICALS INC | Edick Paul R | See Remarks | Mar 11, 2019 | Buy | $9.12 | 30,000 | 273,585 | 155,000 | Mar 12, 2019, 07:15 PM | |
| ITRM | Iterum Therapeutics plc | Edick Paul R | Director | Aug 23, 2018 | Buy | $10.44 | 500 | 5,219 | 25,236 | Aug 27, 2018, 05:15 PM | |
| PDLI | PDL BIOPHARMA, INC. | Edick Paul R | Director | Jun 08, 2018 | Option Exercise | $2.76 | 54,348 | 150,000 | 214,563 | Jun 12, 2018, 04:29 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | Edick Paul R | Director | Feb 13, 2018 | Option Exercise | $18.00 | 14,930 | 268,740 | 0 | Feb 13, 2018, 04:54 PM | |
| PDLI | PDL BIOPHARMA, INC. | Edick Paul R | Director | Jun 09, 2017 | Option Exercise | $2.47 | 60,729 | 150,001 | 160,215 | Jun 12, 2017, 08:19 PM | |
| PDLI | PDL BIOPHARMA, INC. | Edick Paul R | Director | Jun 02, 2016 | Option Exercise | $3.52 | 71,023 | 250,001 | 99,486 | Jun 03, 2016, 06:26 PM | |
| PDLI | PDL BIOPHARMA, INC. | Edick Paul R | Director | Sep 08, 2015 | Option Exercise | $5.27 | 28,463 | 150,000 | 28,463 | Sep 08, 2015, 05:19 PM | |
| DRTX | Durata Therapeutics, Inc. | Edick Paul R | Chief Executive Officer | Jun 12, 2014 | Buy | $15.23 | 3,000 | 45,690 | 45,636 | Jun 13, 2014, 01:53 PM | |
| DRTX | Durata Therapeutics, Inc. | Edick Paul R | Chief Executive Officer | May 20, 2013 | Buy | $7.09 | 3,000 | 21,267 | 43,136 | May 20, 2013, 01:36 PM | |
| DRTX | Durata Therapeutics, Inc. | Edick Paul R | Chief Executive Officer | Aug 14, 2012 | Buy | $8.65 | 5,000 | 43,250 | 24,636 | Aug 16, 2012, 03:03 PM |
Menu